Artikel
Burden and Medical Care of CAncer in SaxoNy (MoCCASiN) – Cancer Prevalence, Incidence, Mortality, and Survival of AOK PLUS beneficiaries – a longitudinal cohort study
Suche in Medline nach
Autoren
-
Thomas Datzmann
- TU Dresden, Medizinische Fakultät Carl Gustav Carus, Center for Evidence-Based Healthcare, Dresden, Germany
-
Olaf Schoffer
- TU Dresden, Medizinische Fakultät Carl Gustav Carus, Center for Evidence-Based Healthcare, Dresden, Germany
-
Jochen Schmitt
- TU Dresden, Medizinische Fakultät Carl Gustav Carus, Center for Evidence-Based Healthcare, Dresden, Germany
| Veröffentlicht: | 2. Oktober 2019 |
|---|
Gliederung
Text
Background: In 2015, there were 17.5 million new cases of cancer and 8.7 million cancer deaths worldwide. Cancer was therefore the second leading cause of death after cardiovascular diseases. Information on the current burden of cancer in Germany is scarce, but necessary to predict the future burden of cancer and healthcare facilities needed for appropriate care.
Methods: We utilized anonymized longitudinal data of a large statutory health insurance of approximately 2.3 million persons living in the German federal state of Saxony.
Results: Applying case definitions based on in- and outpatient diagnosis we identified 167,712 prevalent and 75,360 new onset cancer patients in general within the years 2010 to 2015. Altogether, sex ratio was almost 1:1 and about eight in hundred people were classified as having prevalent cancer in the study period of six years. The average age of the cancer population was at 73.64 (SD 14.1) years. The age-standardized rates of new onset cancer cases of women ranged between 568 and 690 per 100,000 persons, that of men were higher and ranged between 807 and 978 per 100,000 persons. Standardized all-cause mortality rates ranged from 94 to 108 per 1,000 persons for women and from 133 to 152 per 1,000 persons for men (background mortality around 1%). Relative 5-year survival for the year 2015 was 71.5% for women and 63.4% for men. Altogether, the prevalent cancer cases accounted for more than 750 thousand inpatient cases between 2010 and 2015, and caused about 26% of hospital costs of the health insurance collective within the study period.
Discussion: Based on routine healthcare data, we were able to make a comprehensive assessment of the actual cancer burden and medical care in Saxony. However, there is a need for further research in Saxony. In particular, the comparative analysis of different types of cancer could provide information on regional cancer dynamics and differences in medical cancer care as well as on possible deficits.
Keywords: cancer prevalence, new onset cancer, mortality and survival, Saxony
